Literature DB >> 28319053

Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine.

Jin Xu, Zhigang Lu, Ankita Narayan, Valerie P Le Rouzic, Mingming Xu, Amanda Hunkele, Taylor G Brown, William F Hoefer, Grace C Rossi, Richard C Rice, Arlene Martínez-Rivera, Anjali M Rajadhyaksha, Luca Cartegni, Daniel L Bassoni, Gavril W Pasternak, Ying-Xian Pan.   

Abstract

Extensive 3' alternative splicing of the mu opioid receptor gene OPRM1 creates multiple C-terminal splice variants. However, their behavioral relevance remains unknown. The present study generated 3 mutant mouse models with truncated C termini in 2 different mouse strains, C57BL/6J (B6) and 129/SvEv (129). One mouse truncated all C termini downstream of Oprm1 exon 3 (mE3M mice), while the other two selectively truncated C-terminal tails encoded by either exon 4 (mE4M mice) or exon 7 (mE7M mice). Studies of these mice revealed divergent roles for the C termini in morphine-induced behaviors, highlighting the importance of C-terminal variants in complex morphine actions. In mE7M-B6 mice, the exon 7-associated truncation diminished morphine tolerance and reward without altering physical dependence, whereas the exon 4-associated truncation in mE4M-B6 mice facilitated morphine tolerance and reduced morphine dependence without affecting morphine reward. mE7M-B6 mutant mice lost morphine-induced receptor desensitization in the brain stem and hypothalamus, consistent with exon 7 involvement in morphine tolerance. In cell-based studies, exon 7-associated variants shifted the bias of several mu opioids toward β-arrestin 2 over G protein activation compared with the exon 4-associated variant, suggesting an interaction of exon 7-associated C-terminal tails with β-arrestin 2 in morphine-induced desensitization and tolerance. Together, the differential effects of C-terminal truncation illustrate the pharmacological importance of OPRM1 3' alternative splicing.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28319053      PMCID: PMC5373896          DOI: 10.1172/JCI88760

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  77 in total

1.  A novel endocytic recycling signal that distinguishes the membrane trafficking of naturally occurring opioid receptors.

Authors:  Michael Tanowitz; Mark von Zastrow
Journal:  J Biol Chem       Date:  2003-08-25       Impact factor: 5.157

2.  Comparative immunohistochemical distributions of carboxy terminus epitopes from the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat CNS.

Authors:  C Abbadie; Y Pan; C T Drake; G W Pasternak
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

3.  A novel knock-in mouse reveals mechanistically distinct forms of morphine tolerance.

Authors:  Johan Enquist; Joseph A Kim; Selena Bartlett; Madeline Ferwerda; Jennifer L Whistler
Journal:  J Pharmacol Exp Ther       Date:  2011-05-11       Impact factor: 4.030

4.  Enhanced morphine analgesia in mice lacking beta-arrestin 2.

Authors:  L M Bohn; R J Lefkowitz; R R Gainetdinov; K Peppel; M G Caron; F T Lin
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

5.  T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice.

Authors:  Xiao-Fei Wang; Elisabeth Barbier; Yi-Ting Chiu; Yi He; Jia Zhan; Guo-Hua Bi; Hai-Ying Zhang; Bo Feng; Lee-Yuan Liu-Chen; Jia Bei Wang; Zheng-Xiong Xi
Journal:  J Neurosci       Date:  2016-10-05       Impact factor: 6.167

6.  An octaguanidine-morpholino oligo conjugate improves muscle function of mdx mice.

Authors:  Jeffrey J Widrick; Shan Jiang; Seung Jun Choi; Shannon T Knuth; Paul A Morcos
Journal:  Muscle Nerve       Date:  2011-10       Impact factor: 3.217

7.  Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice.

Authors:  Laura M Bohn; Robert J Lefkowitz; Marc G Caron
Journal:  J Neurosci       Date:  2002-12-01       Impact factor: 6.167

8.  Morphine side effects in beta-arrestin 2 knockout mice.

Authors:  Kirsten M Raehal; Julia K L Walker; Laura M Bohn
Journal:  J Pharmacol Exp Ther       Date:  2005-05-25       Impact factor: 4.030

Review 9.  Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management.

Authors:  Folabomi A Oladosu; William Maixner; Andrea G Nackley
Journal:  Mayo Clin Proc       Date:  2015-08       Impact factor: 7.616

10.  Repeated low doses of morpholino antisense oligomer: an intermediate mouse model of spinal muscular atrophy to explore the window of therapeutic response.

Authors:  Haiyan Zhou; Jinhong Meng; Elena Marrosu; Narinder Janghra; Jennifer Morgan; Francesco Muntoni
Journal:  Hum Mol Genet       Date:  2015-08-11       Impact factor: 5.121

View more
  27 in total

1.  A Truncated Six Transmembrane Splice Variant MOR-1G Enhances Expression of the Full-Length Seven Transmembrane μ-Opioid Receptor through Heterodimerization.

Authors:  Tiffany Zhang; Jin Xu; Ying-Xian Pan
Journal:  Mol Pharmacol       Date:  2020-07-28       Impact factor: 4.436

2.  A "tail" of opioid receptor variants.

Authors:  Stephanie Puig; Howard B Gutstein
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

Review 3.  Molecular Genetics and New Medication Strategies for Opioid Addiction.

Authors:  Yasmin L Hurd; Charles P O'Brien
Journal:  Am J Psychiatry       Date:  2018-08-02       Impact factor: 18.112

Review 4.  Opioid and chemokine regulation of cortical synaptodendritic damage in HIV-associated neurocognitive disorders.

Authors:  Bradley Nash; Lindsay Festa; Chihyang Lin; Olimpia Meucci
Journal:  Brain Res       Date:  2019-08-26       Impact factor: 3.252

5.  Truncated μ-Opioid Receptors With 6 Transmembrane Domains Are Essential for Opioid Analgesia.

Authors:  Zhigang Lu; Jin Xu; Mingming Xu; Grace C Rossi; Susruta Majumdar; Gavril W Pasternak; Ying-Xian Pan
Journal:  Anesth Analg       Date:  2018-03       Impact factor: 5.108

6.  Pharmacological Characterization of Levorphanol, a G-Protein Biased Opioid Analgesic.

Authors:  Valerie Le Rouzic; Ankita Narayan; Amanda Hunkle; Gina F Marrone; Zhigang Lu; Susruta Majumdar; Jin Xu; Ying-Xian Pan; Gavril W Pasternak
Journal:  Anesth Analg       Date:  2019-02       Impact factor: 5.108

Review 7.  Toward Directing Opioid Receptor Signaling to Refine Opioid Therapeutics.

Authors:  Travis W Grim; Agnes Acevedo-Canabal; Laura M Bohn
Journal:  Biol Psychiatry       Date:  2019-10-31       Impact factor: 13.382

Review 8.  Interactive Mechanisms of Supraspinal Sites of Opioid Analgesic Action: A Festschrift to Dr. Gavril W. Pasternak.

Authors:  Grace C Rossi; Richard J Bodnar
Journal:  Cell Mol Neurobiol       Date:  2020-09-24       Impact factor: 5.046

Review 9.  Opioid Modulation of Neuronal Iron and Potential Contributions to NeuroHIV.

Authors:  Bradley Nash; Elena Irollo; Renato Brandimarti; Olimpia Meucci
Journal:  Methods Mol Biol       Date:  2021

Review 10.  Conformational Basis of G Protein-Coupled Receptor Signaling Versatility.

Authors:  Laura M Wingler; Robert J Lefkowitz
Journal:  Trends Cell Biol       Date:  2020-07-02       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.